Catheter Precision, Inc.
VTAK · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | -0.51 | 0.06 | 0.09 |
| FCF Yield | -13.38% | -3.74% | -3.18% | -4.17% |
| EV / EBITDA | -11.81 | -13.00 | -23.99 | -35.44 |
| Quality | ||||
| ROIC | -13.13% | -17.23% | -13.43% | -26.60% |
| Gross Margin | 92.04% | 93.40% | 92.31% | 92.62% |
| Cash Conversion Ratio | 0.97 | 0.41 | 0.58 | 0.51 |
| Growth | ||||
| Revenue 3-Year CAGR | 32.47% | 49.10% | 74.84% | 210.72% |
| Free Cash Flow Growth | -94.03% | 2.26% | 18.02% | -16.80% |
| Safety | ||||
| Net Debt / EBITDA | -0.80 | -2.45 | -3.29 | 0.57 |
| Interest Coverage | 86.31 | -69.94 | -72.73 | -59.82 |
| Efficiency | ||||
| Inventory Turnover | 0.53 | 0.29 | 0.15 | 0.33 |
| Cash Conversion Cycle | -5,176.02 | -4,811.18 | -4,659.23 | -1,569.54 |